SCHEMBL2633117

SCHEMBL2633117

COP1(=O)OCCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14748684 0.78 ACHE (0.39)
SCHEMBL8530824 0.77
SCHEMBL25586518 0.77
SCHEMBL4895268 0.72
SCHEMBL28524209 0.72
SCHEMBL14428519 0.72 ACHE (0.33)
SCHEMBL30736104 0.72
SCHEMBL2627461 0.72
SCHEMBL11630121 0.70 ACHE (0.31)
SCHEMBL26944829 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220033432-A1 ANTI-HEPATITIS B VIRUS AGENT DAIKIN INDUSTRIES, LTD. (JP) 2022-02-03 US disclosed
US-20220029200-A1 Electrolyte for Lithium Secondary Battery and Lithium Secondary Battery Including the Same SK ON CO., LTD. (KR) 2022-01-27 US disclosed
US-20220008450-A1 ANTI-HEPATITIS B VIRUS AGENT DAIKIN INDUSTRIES, LTD. (JP) 2022-01-13 US disclosed
US-11177507-B2 Electrolyte for lithium secondary battery and lithium secondary battery including the same SK INNOVATION CO., LTD. (KR) 2021-11-16 US disclosed
WO-2021183790-A1 METHOD FOR TREATMENT OF COVID-19-ASSOCIATED CONDITIONS RIGEL PHARMACEUTICALS, INC. (US) 2021-09-16 WO disclosed
EP-3730509-A1 COMPOUND FOR TREATING METABOLIC DISEASES AND PREPARATION METHOD AND USE THEREOF Xi' An Biocare Pharma (CN) 2020-10-28 EP disclosed
WO-2020158951-A1 ANTI-HEPATITIS C VIRUS AGENT ダイキン工業株式会社 2020-08-06 WO disclosed
US-20200127333-A1 Electrolyte for Lithium Secondary Battery and Lithium Secondary Battery Including the Same SK ON CO., LTD. (KR) 2020-04-23 US disclosed
WO-2020045628-A1 NUCLEIC ACID ANALOG AND ANTI-HEPATITIS B VIRUS AGENT ダイキン工業株式会社 2020-03-05 WO disclosed
US-20170291909-A1 Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses RIGEL PHARMACEUTICALS, INC. (US) 2017-10-12 US disclosed
US-7538108-B2 Prodrugs of 2,4-pyrimidinediamine compounds and their uses RIGEL PHARMACEUTICALS, INC. (US) 2009-05-26 US disclosed
US-20090124580-A1 Autoimmune diseases; water solubility of prodrug can be tailored to improve bioavailability using substution at amine groups; inhibitors of degranulation of immune cells; inhibit/activate Fc receptor signaling cascades RIGEL PHARMACEUTICALS, INC. 2009-05-14 US disclosed
US-20080199804-A1 Including free radical binder polymer containing functional group having dipole moment of 3.8 debye; laser computer controlled direct plate making without alkali development; sensitivity, printing durability FUJIFILM CORPORATION (JP) 2008-08-21 US disclosed
US-20080199804-A1 Including free radical binder polymer containing functional group having dipole moment of 3.8 debye; laser computer controlled direct plate making without alkali development; sensitivity, printing durability FUJIFILM CORPORATION (JP) 2008-08-21 US disclosed
US-20080171272-A1 CURABLE COMPOSITION, COLOR FILTER USING THE SAME AND MANUFACTUIRNG METHOD THEREFOR, AND SOLID IMAGE PICKUP ELEMENT FUJIFILM CORPORATION (JP) 2008-07-17 US disclosed
US-20080171272-A1 CURABLE COMPOSITION, COLOR FILTER USING THE SAME AND MANUFACTUIRNG METHOD THEREFOR, AND SOLID IMAGE PICKUP ELEMENT FUJIFILM CORPORATION (JP) 2008-07-17 US disclosed
EP-0879838-B1 Process of preparation of a polymer in the presence of a phosphazenium salt MITSUI CHEMICALS INC (JP) 2005-04-20 EP disclosed
JP-2000252168-A ELECTROCHEMICAL CAPACITOR MITSUBISHI CHEMICALS CORP 2000-09-14 JP disclosed
US-6077930-A RING-OPENING POLYMERIZATION OF A 4-TO 10-MEMBERED RING-OPENING POLYMERIZABLE CYCLIC MONOMER IN THE PRESENCE OF A PHOSPHAZENIUM SALT OF AN ACTIVE HYDROGEN COMPOUND MITSUI CHEMICALS, INC. (JP) 2000-06-20 US disclosed
EP-0879838-A2 Process of preparation of a polymer in the presence of a phosphazenium salt Mitsui Chemicals, Inc. (JP) 1998-11-25 EP disclosed